Date | Panel | Item | Activity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
COVID-19 research v0.36 | IFNGR2 |
Ellen McDonagh gene: IFNGR2 was added gene: IFNGR2 was added to Viral susceptibility. Sources: Expert Review Green,ESID Registry 20171117,North West GLH,Victorian Clinical Genetics Services,GRID V2.0,NHS GMS,London North GLH,IUIS Classification February 2018 Mode of inheritance for gene: IFNGR2 was set to BOTH monoallelic and biallelic, autosomal or pseudoautosomal Publications for gene: IFNGR2 were set to 9616207; 18625743; 30264912; 15924140 Phenotypes for gene: IFNGR2 were set to Susceptibility to mycobacteria and Salmonella; Defects with susceptibility to mycobacterial infection (MSMD); Immunodeficiency 28, Mycobacteriosis, 614889; Defects in Intrinsic and Innate Immunity |